National Cholesterol Education Program Adult Treatment Panel III versus International Diabetic Federation definition of metabolic syndrome, which one is associated with diabetes mellitus and coronary artery disease?

International Journal of Preventive Medicine

Volumn 3, Issue 8, 2012, Pages 552-558

  Rezaianzadeh, Abbas ^a   Namayandeh, Seyedeh Mahdieh ^b   Sadr, Seyed Mahmood ^c  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c YAZD UNIVERSITY   (Iran)

Author keywords

Diabetes mellitus; International diabetes federation; Metabolic syndrome

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMMUNITY CARE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HEALTH CARE ORGANIZATION; HEALTH PROGRAM; HUMAN; HYPERLIPIDEMIA; INTERNATIONAL DIABETIC FEDERATION; IRAN; MAJOR CLINICAL STUDY; MALE; MEDICAL TERMINOLOGY; METABOLIC SYNDROME X; NATIONAL CHOLESTEROL EDUCATION PROGRAM ADULT TREATMENT PANEL III; PREDICTION; PREVALENCE; SEX DIFFERENCE; STABLE ANGINA PECTORIS; URBAN POPULATION;

EID: 84865094355     PISSN: 20087802     EISSN: 20088213     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Hanley AJ, Karter AJ, Festa A, D'Agostino R Jr, Wagenknecht LE, Savage P, et al. Factor analysis of metabolic syndrome using directly measured insulin sensitivity: The Insulin Resistance Atherosclerosis Study. Diabetes 2002;51:2642-7.
2. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005;365:1415-28.
3. World Health Organization: Definition, Diagnosis, and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus: Report of a WHO consultation. In: Alwan A, King H, Editors. Department of Noncommunicable Disease Surveillance, Geneva: World Health Organization; 1999. p. 1-59.
4. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
5. Balkau B, Charles MA, Drivsholm T, Borch-Johnsen K, Wareham N, Yudkin JS, et al. Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab 2002;28:364-76.
6. Einhorn D, Reaven GM, Cobin RH, Ford E, Ganda OP, Handelsman Y, et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract 2003;9:237-52.
7. Grundy SM, Cleeman JI, Daniels SR, Donato KA, EckelRH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 2005;112:2735-52.
8. Saely CH, Koch L, Schmid F, Marte T, Aczel S, Langer P, et al. Adult treatment panel III 2001 but not international diabetes federation 2005 criteria of the metabolic syndrome predict clinical cardiovascular events in subjects who underwent coronary angiography. Diabetes Care 2006;29:901-7.
9. Rigo JC, Vieira JL, Dalacorte RR, Reichert CL. Prevalence of Metabolic Syndrome in an Elderly Community: Comparison between Three Diagnostic Methods. Arq Bras Cardiol 2009;93:80-6.
10. Sarraf-Zadegan N, Boshtam M, Rafiei M. Risk factors for coronary artery disease in Isfahan, Iran. Euro J Public Health 1999;9:20-6.
11. Fischbacher C, Bhopal R, Unwin N, White M, AlbertiK. The performance of the rose angina questionnaire in south Asian and European origin population: A comparative study in Newcastle, UK. Int J Epidemiol 2001;30:1009-16.
12. Zhou H, Hu XS, Guo JT, Zhou ZY, Yao CL. A comparison of applicability in three diagnostic criteria of metabolic syndrome in Jiangsu population. Zhoghua Ya Fang Yi Xue Za Zhi 2009;43:117-21.
13. Valenzuela AA, Maíz A, Margozzini P, FerreccioC, RigottiA, Olea R, et al. Prevalence of metabolic syndrome among Chilean adults. Rev Med Chil 2010;138:707-14.
14. Correia F, Poínhos R, Freitas P, Pinhão S, MaiaA, Carvalho D, et al. Prevalence of the metabolic syndromecomparison between ATP III and IDF criteria in a feminine population with Severe Obesity. Acta Med Port 2006;19:286-94.
15. Ma XJ, Jia WP, Hu C, Zhou J, Lu HJ, Zhang R, et al. Comparison of applicability in three diagnostic criteria of metabolic syndrome in familial type2 diabetes pedigrees. Zhoghua Ya Fang Yi Xue Za Zhi 2009;43:489-94.
16. Hadaegh F, Zabetian A, Tohidi M, Ghasemi A, Sheikholeslami F, Azizi F. Prevalence of metabolic syndrome by the adult treatment Panel III, International Diabetes Federation, and World Health Organization Definitions and their association with coronary heart disease in an elderly Iranian Population. Ann Acad Med Singapore 2009;38:142-9.
17. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type2 diabetes mellitus. Circulation 2005;112:3066-72.
18. Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DS, Haffner SM, et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003;108:414-9.
19. Lorenzo C, Williams K, Hunt KJ, Haffner SM. The national cholesterol education program-adult treatment panel III, international diabetes federation, and world health organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes metabolic syndrome as a disease marker. Diabetes Care 2007;30:8-13.
20. Zhou H, Guo ZR, Yu LG, Hu XS, Xu BH, Liu HB, et al. Evidence on the applicability of the ATPIII and CDS metabolic syndrome diagnostic criteria to identify CVD and T2DM in the Chinese population from a 6.3-year cohort study in mid-eastern China. Diabetes Res Clin Pract 2010;90:319-25.
21. Guzder RN, Gatling W, Mullee MA, Byrne CD. Impact of metabolic syndrome criteria on cardiovascular disease risk in people with newly diagnosed type2 diabetes. Diabetologia 2006;49:49-55.
22. Bonora E, Targher G, Formentini G, Calcaterra F, Lombardi S, Marini F, et al. The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study. Diabetes Med 2003;21:52-8.